Clinical Course and Flow Cytometric Analysis of Paroxysmal Nocturnal Hemoglobinuria in the United States and Japan-Reference-Cited by-同舟云学术

Clinical Course and Flow Cytometric Analysis of Paroxysmal Nocturnal Hemoglobinuria in the United States and Japan

Published:2004-05 Issue:3 Volume:83 Page:193-207
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Nishimura Jun-Ichi,Kanakura Yuzuru,Ware Russell E.,Shichishima Tsutomu,Nakakuma Hideki,Ninomiya Haruhiko,Decastro Carlos M.,Hall Sharon,Kanamaru Akihisa,Sullivan Keith M.,Mizoguchi Hideaki,Omine Mitsuhiro,Kinoshita Taroh,Rosse Wendell F.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference47 articles.

1. Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals.;Araten;Proc Natl Acad Sci U S A,1999

2. CD59-deficient blood cells and PIG-A gene abnormalities in Japanese patients with aplastic anaemia.;Azenishi;Br J Haematol,1999

3. Flow cytometry testing in PNH. How much is enough?;Borowitz;Cytometry,2000

4. Resistance of paroxysmal nocturnal hemoglobinuria cells to the glycosylphosphatidylinositol-binding toxin aerolysin.;Brodsky;Blood,1999

5. Improved detection and characterization of paroxysmal nocturnal hemoglobinuria using fluorescent aerolysin.;Brodsky;Am J Clin Pathol,2000

Cited by 203 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnosis and management of acquired aplastic anemia in childhood. Guidelines from the Marrow Failure Study Group of the Pediatric Haemato-Oncology Italian Association (AIEOP);Blood Cells, Molecules, and Diseases;2024-09

2. Three Years On: The Role of Pegcetacoplan in Paroxysmal Nocturnal Hemoglobinuria (PNH) since Its Initial Approval;International Journal of Molecular Sciences;2024-08-09

3. An Interesting Case of Paroxysmal Nocturnal Hemoglobinuria With Renal Involvement;Cureus;2024-07-05

4. Phase 3 randomized COMMODORE 1 trial: Crovalimab versus eculizumab in complement inhibitor‐experienced patients with paroxysmal nocturnal hemoglobinuria;American Journal of Hematology;2024-06-25

5. Efficacy, Safety, and Quality of Life of Pegcetacoplan in Japanese Patients with Paroxysmal Nocturnal Hemoglobinuria Treated within the Phase 3 PEGASUS Trial;Acta Haematologica;2024-04-17